{"title":"新型嘧啶基磺酰胺衍生物作为GPR17调节剂。","authors":"Taoqian Zhao, Steven H Liang","doi":"10.1021/acsmedchemlett.5c00012","DOIUrl":null,"url":null,"abstract":"<p><p>The present invention relates to novel pyrimidinyl sulfonamide derivatives represented by formula I. These compounds are specifically designed to bind to and modulate GPR17 activities, making them particularly promising for treating diseases associated with GPR17 antagonism.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 3","pages":"361-362"},"PeriodicalIF":4.0000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11912259/pdf/","citationCount":"0","resultStr":"{\"title\":\"Novel Pyrimidinyl Sulfonamide Derivatives as GPR17 Modulators.\",\"authors\":\"Taoqian Zhao, Steven H Liang\",\"doi\":\"10.1021/acsmedchemlett.5c00012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The present invention relates to novel pyrimidinyl sulfonamide derivatives represented by formula I. These compounds are specifically designed to bind to and modulate GPR17 activities, making them particularly promising for treating diseases associated with GPR17 antagonism.</p>\",\"PeriodicalId\":20,\"journal\":{\"name\":\"ACS Medicinal Chemistry Letters\",\"volume\":\"16 3\",\"pages\":\"361-362\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-01-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11912259/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Medicinal Chemistry Letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acsmedchemlett.5c00012\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/13 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsmedchemlett.5c00012","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/13 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Novel Pyrimidinyl Sulfonamide Derivatives as GPR17 Modulators.
The present invention relates to novel pyrimidinyl sulfonamide derivatives represented by formula I. These compounds are specifically designed to bind to and modulate GPR17 activities, making them particularly promising for treating diseases associated with GPR17 antagonism.
期刊介绍:
ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to:
Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics)
Biological characterization of new molecular entities in the context of drug discovery
Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc.
Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry
Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources
Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response
Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic
Mechanistic drug metabolism and regulation of metabolic enzyme gene expression
Chemistry patents relevant to the medicinal chemistry field.